News/ News/ R&D RNAi biotech Atalanta debuts with $110m plus Biogen and Roche CNS tie-ups Richard Staines Atalanta Therapeutics, Biogen, Genentech, Huntington's, neurology, Parkinson's, Roche 0 Comment US biotech Atalanta Therapeutics has come out of stealth mode backed with $110m from Biogen and Roche, who Share X RNAi biotech Atalanta debuts with $110m plus Biogen and Roche CNS tie-ups https://pharmaphorum.com/news/rnai-biotech-atalanta-debuts-with-110m-plus-biogen-and-roche-cns-tie-ups/